Indoco Remedies · NSE: INDOCO · BSE: 532612
Q1 FY20 results · Apr–Jun 2019
Indoco Remedies reported revenue from operations of ₹252.67 crore (up 18.9% from Q1 FY19) and net profit of ₹2.18 crore for Q1 FY20 (Apr–Jun 2019), on a standalone basis.
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 252.67 | 212.49 | +18.9% | 252.02 | +0.3% |
| Other income | 0.64 | 5.35 | −88.0% | 4.94 | −87.0% |
| Total income | 253.31 | 217.84 | +16.3% | 256.96 | −1.4% |
| Profit before tax | 0.28 | (12.02) | Turned profit | 9.40 | −97.0% |
| Net profit for the period | 2.18 | (12.02) | Turned profit | 11.63 | −81.3% |
| EPS, basic (₹) | 0.24 | (1.30) | Turned profit | 1.26 | −81.0% |
| Net margin (%) | 0.9 | -5.7 | 4.6 |
Standalone
- Filed with BSE
- 13 Aug 2019, 19:02 IST
- Board meeting
- 18 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE